scholarly journals Pharmacokinetic and Biodistribution Studies of a Bone-Targeting Drug Delivery System Based onN-(2-Hydroxypropyl)methacrylamide Copolymers

2006 ◽  
Vol 3 (6) ◽  
pp. 717-725 ◽  
Author(s):  
Dong Wang ◽  
Monika Sima ◽  
R. Lee Mosley ◽  
Jasmine P. Davda ◽  
Nicole Tietze ◽  
...  
1984 ◽  
Vol 12 (6) ◽  
pp. 1064-1065 ◽  
Author(s):  
SUSAN A. CARTLIDGE ◽  
PAVLA REJMANOVÁ ◽  
RUTH DUNCAN ◽  
JINDŘICH KOPEČEK ◽  
JOHN B. LLOYD

2020 ◽  
Vol 108 (4) ◽  
pp. 1351-1362 ◽  
Author(s):  
Carlos Soriano‐Souza ◽  
Helder Valiense ◽  
Elena Mavropoulos ◽  
Victor Martinez‐Zelaya ◽  
Andrea Machado Costa ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (2) ◽  
pp. 106 ◽  
Author(s):  
Larisa Janisova ◽  
Andrey Gruzinov ◽  
Olga V. Zaborova ◽  
Nadiia Velychkivska ◽  
Ondřej Vaněk ◽  
...  

The binding of plasma proteins to a drug carrier alters the circulation of nanoparticles (NPs) in the bloodstream, and, as a consequence, the anticancer efficiency of the entire nanoparticle drug delivery system. We investigate the possible interaction and the interaction mechanism of a polymeric drug delivery system based on N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers (pHPMA) with the most abundant proteins in human blood plasma—namely, human serum albumin (HSA), immunoglobulin G (IgG), fibrinogen (Fbg), and apolipoprotein (Apo) E4 and A1—using a combination of small-angle X-ray scattering (SAXS), analytical ultracentrifugation (AUC), and nuclear magnetic resonance (NMR). Through rigorous investigation, we present evidence of weak interactions between proteins and polymeric nanomedicine. Such interactions do not result in the formation of the protein corona and do not affect the efficiency of the drug delivery.


2017 ◽  
Vol 17 (3) ◽  
pp. 1747-1752 ◽  
Author(s):  
Erica J Carbone ◽  
Komal Rajpura ◽  
Tao Jiang ◽  
Ho-Man Kan ◽  
Xiaohua Yu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document